← FDA Drug Approvals (Drugs@FDA)
VIGABATRIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SPECGX LLC · Approved 2021-07-28
Drug application
- FDA Application #
ANDA212626- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- VIGABATRIN
- Generic name
- Vigabatrin
- Active ingredients
- VIGABATRIN
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SPECGX LLC
- First approval
- 2021-07-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown